Organization
Acadia Pharmaceuticals Inc.
15 clinical trials
Clinical trial
A 52-Week Open-label Extension Study of Pimavanserin in Adult and Elderly Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseStatus: Completed, Estimated PCD: 2023-05-05
Clinical trial
A 52-Week, Open-Label Extension Study of ACP-204 in Adults With Alzheimer's Disease PsychosisStatus: Not yet recruiting, Estimated PCD: 2029-04-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Trofinetide for the Treatment of Girls and Women With Rett SyndromeStatus: Completed, Estimated PCD: 2021-10-28
Clinical trial
A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaStatus: Active (not recruiting), Estimated PCD: 2025-01-01
Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum DisorderStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A 40-Week, Open-label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett SyndromeStatus: Completed, Estimated PCD: 2022-08-19
Clinical trial
A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease PsychosisStatus: Recruiting, Estimated PCD: 2028-01-01
Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of SchizophreniaStatus: Active (not recruiting), Estimated PCD: 2024-01-01
Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the KneeStatus: Terminated, Estimated PCD: 2022-08-12
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ACP-044 for Acute Postoperative Pain Following Orthopedic Surgery (Bunionectomy)Status: Completed, Estimated PCD: 2022-02-11
Clinical trial
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett SyndromeStatus: Completed, Estimated PCD: 2023-05-31
Clinical trial
An Open-Label Extension Study of Continuing Treatment With Trofinetide for Rett SyndromeStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeStatus: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
A 52-Week Open-Label Extension Study of Pimavanserin in Children and Adolescents With Irritability Associated With Autism Spectrum Disorder (ASD)Status: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Long-term, Open-label Extension Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeStatus: , Estimated PCD: 2029-05-01